We are searching data for your request:
Upon completion, a link will appear to access the found materials.
V. cholerae secrete choleragen to grow and escape human intestines, however choleragen does not work on other mammals, why so? Why didn't it evolve a general mammal affecting choleragen? This question is a continuation of the last comment on the only answer for my previous question, How does Vibrio cholerae benefit from infecting its host? Kindly refer to the answer and comments in that question as well.
Vibrio cholerae originated in the Sundarbans, a very large wetland at the mouth of the Bay of Bengal. Although it can exist as free living, it is much more fecund when associated with tiny crustaceans called copepods. In 1760, the East India Company settled and sprawled, hewing the mangroves and planting rice. So, that was the first opportunity of note introducing V. cholerae to a major species of land animal, humans. The frequent contact with a sizable population of humans, plus time, allowed V. cholerae to evolve the traits to become a parasite.
For example, a hair-like filament evolved which allowed the cells to clump together forming colonies that could stick to the gut. At that point, perhaps with additional traits, V. cholerae became a zoonosis. That is, a disease we acquire from animals, copepods in this case, but not directly from other humans. Further evolution over time gave it the traits to spread directly between humans making it a true human pathogen.
So, humans were the species that became available and V. cholerae evolved to take advantage.
This is a minute fraction of the whole story as related in the 2016 book Pandemic by Sonia Shah. She is a science writer, the book is extremely well referenced. Since this is your second question on this, I suspect you may well be interested in the book.
Science : Cholera's deadly hitchhiker
THE toxin that makes cholera lethal belongs not to the cholera bacterium
itself, but to a threadlike virus which hijacks it to hitch a ride into cells.
This discovery, by researchers in the US, helps to explain how bacteria can
suddenly turn nasty and cause “new” diseases with the help of genetic material
from a virus.
While several other bacterial diseases, including diphtheria and botulism,
are known to be triggered by toxins from viruses that infect them, until now no
one has seen a virus use such ingenious means. The new work, by John Mekalanos
and Matthew Waldor at Harvard Medical School, shows for the first time just how
much control a virus can exert over its bacterial host. “The biology of the
virus itself is intimately tied to the properties that allow the bacterium to
cause disease,” says Mekalanos.
More ominously, the researchers suggest that there may be an entire
threadlike, or filamentous, bacterial viruses that can rapidly move their
genetic material between different species of common gut bacteria, using the
mechanism the team has discovered. “We’ve seen it so far moving between two
strains of Vibrio cholerae [the cholera bacterium] but there is no
reason why it should not move from, say, V. cholerae to
Shigella,” says Mekalanos. Shigella causes dysentery.
In laboratory cultures, the virus moved relatively little between two
of V. cholerae. But when the team watched its behaviour in the more
realistic setting of the guts of mice, where natural selection comes into play,
the virus increased its rate of movement between the strains by a factor of 10
million (Science, vol 272, p 1910).
V. cholerae normally lives in coastal waters. Only a small minority
of strains are adapted to survive in the human gut and cause disease. In 1987,
Mekalanos’s team discovered a key difference between the disease-causing
minority and their harmless cousins: the dangerous strains make thousands of
hair-like fibres, called pili, with which they attach themselves to gut cells.
Without the pili, these strains would be incapable of colonising the gut. Once
their pili are attached, the disease-causing strains start to produce their
lethal toxin. It was clear to the researchers, even then, that the toxin is
produced only when pili are present. But at that stage they did not know
Almost a decade of molecular detective work later, they have the
answer—a virus that choreographs the whole show. “If it were our goal to
devise a way to turn V. cholerae into a successful pathogen, we could
not have figured out a better way to do it,” says Mekalanos. Their suspicions
were roused when they found that the sequence of genes which encodes the
toxin in disease-causing strains is capable of jumping from one bacterium to
another. They also found particles outside cells which contained DNA that
matched these toxin-encoding genes. The DNA was single-stranded—a
characteristic feature of other filamentous bacterial viruses.
But it was the transmission mechanism of the virus, dubbed CTX, that
impressed the team most. It finds its way into the bacterium through the pili,
using them as its receptors. It then introduces its own genes—which
the toxin—into the bacterial genome.
The origins of the CTX virus are a mystery. “The virus has not evolved
V. cholerae,” says Mekalanos. He suggests that its original host was a
bacterium that perhaps infected a marine mammal, such as a dolphin or
toxin is specific for mammalian cells, and other species in the Vibrio
group of bacteria are known to infect marine mammals.
The virus’s ability to use pili as its receptor makes it capable, in
principle, of turning other bacteria into vicious killers. Many common gut
bacteria, including Escherichia coli and Shigella, make pili.
“A virus is not going to be limited to the bacterium it lives on if the
is not limited to that bacterium,” says Mekalanos.
Mekalanos and Waldor believe that the CTX virus must have infiltrated a
once-harmless strain of V. cholerae to create the strain responsible
for the first great cholera pandemic of 1817. Another, separate infiltration by
the same virus probably created the El Tor strain that began the more recent
pandemic in 1961. The outbreaks that have affected Peru, South Asia and
the 1990s appear to be relatives of earlier strains and so are unlikely to be
caused by new infiltrations, says Mekalanos.
“This is a terrific paper,” says Barry Bloom, a leading microbiologist at
Yeshiva University, New York. But, he warns, it doesn’t bode well for
experimental cholera vaccines based on live, weakened bacteria whose toxin genes
have been removed. The virus could ferry the toxin genes back into these
Illness and Symptoms
Cholera is an acute diarrheal illness caused by infection of the intestine with Vibrio cholerae bacteria. People can get sick when they swallow food or water contaminated with cholera bacteria. The infection is often mild or without symptoms, but can sometimes be severe and life-threatening.
A physician checking a patient for dehydration
About 1 in 10 people with cholera will experience severe symptoms, which, in the early stages, include:
- profuse watery diarrhea, sometimes described as &ldquorice-water stools&rdquo
- leg cramps
- restlessness or irritability
Health care providers should look for signs of dehydration when examining a patient with profuse watery diarrhea. These include:
- rapid heart rate
- loss of skin elasticity
- dry mucous membranes
- low blood pressure
People with severe cholera can develop severe dehydration, which can lead to kidney failure. If left untreated, severe dehydration can lead to shock, coma, and death within hours.
Person washing hands over a bucket of water.
The profuse diarrhea produced by cholera patients contains large amounts of the infectious Vibrio cholerae germ that can infect others if swallowed. This can happen when the bacteria get on food or into water.
To prevent the bacteria from spreading, all feces (human waste) from sick persons should be thrown away carefully to ensure it does not contaminate anything nearby.
People caring for cholera patients must wash their hands thoroughly after touching anything that might be contaminated with patients&rsquo feces (poop).
When cholera patients are treated quickly, they usually recover without long-term consequences. Cholera patients do not typically become carriers of the cholera bacteria after they recover, but they get sick if exposed again.
Cholera toxin: from structure to function
CT is made up of two types of subunits. The larger A subunit (240 amino acids MW 28 kD) is located centrally, while the five B subunits (103 amino acids MW 11 kD each aggregate MW
56 kD) are located peripherally. The A subunit of CT has over 82 per cent sequence identity with the Escherichia coli heat-labile enterotoxin (LT), while the B subunits of the former shares over 83 per cent sequence identity with the latter 10 . The elucidation of the three-dimensional structure of CT was a major achievement to enhance our understanding of this remarkable toxin 11 ,12 . The three-dimensional structure of CT further corroborated the sequence data that it shared a similar structure to LT, the crystal structure of which had been determined a few years earlier 13 ,14 . The A subunit consists of two domains (A1 and A2). In both the toxins, the upper A1 domain of the wedge-shaped A subunit is held above the plane of the doughnut-shaped pentameric B subunits by the tethering A2 domain, which in case of CT, is an alpha helix for almost its entire length. The carboxy-terminal of the A2 passes through the opening created by the doughnut arrangement of the B subunits. The four carboxy-terminal residues of the A2 chain are Lys-Asp-Glu-Leu (K-D-E-L).
Cholera toxin, by acting as a classical A-B type toxin, leads to ADP-ribosylation of G protein, and constitutive activation of AC, thereby giving rise to increased levels of cyclic AMP within the host cell ( Fig. 1 ). As a result, electrolyte imbalance occurs due to a rapid efflux of chloride ions by the cystic fibrosis trans-membrane conductance regulator (CFTR), decreased influx of sodium ions, leading to massive water efflux through the intestinal cells, thereby causing severe diarrhoea and vomiting, the cardinal clinical signs of cholera. Diarrhoea, if untreated, leads to severe dehydration, electrolyte abnormalities and metabolic acidosis 15 , almost inevitably resulting in death.
ADP-ribosylation. The 22kD A1 domain of CT (CTA1) catalyzes the transfer of the ADP-ribose moiety of NAD + to an Arginine residue (Arg 201 ) of the α subunit of Gs, leading to defective regulation of adenylyl cyclase and overproduction cAMP.
The toxic action of CT is initiated by binding of its B subunits to the high-affinity monosialoganglioside GM1 receptors. Each B subunit monomer has a binding site for GM1. Moreover, a single amino acid from a neighbouring B subunit also plays an important role in binding 16 , explaining the much higher binding affinity of the CTB pentamer, as compared to that of the CTB monomer. Endocytosis of CT may follow one of three pathways: (i) lipid raft/caveolae mediated endocytic pathway, (ii) clathrin mediated endocytic pathway, or (iii) ADP-ribosylation factor 6 (Arf6)-associated endocytic pathway. CT then travels to the endoplasmic reticulum (ER) in a retrograde fashion. After reaching the ER, the A subunit of CT (CTA) dissociates from its B subunit (CTB). Earlier studies indicated that a functional Golgi apparatus was essential 17 in this transportation pathway, but later studies showed that the Golgi system was not mandatory 18 . It was initially thought that the KDEL signal, present at the carboxy-terminal of CTA2, which is a classical eukaryotic signal for ER retention, was essential for retrograde trafficking. However, mutagenesis and blocking studies have indicated that this signal is not essential for retrograde transport, but rather, serves for the retrieval of the dissociated CTA from the Golgi apparatus to the ER 17 ,18 . This observation has been strengthened by the fact that CTB, which does not possess a KDEL signal, is also transported to the ER in a retrograde fashion 19 . The ADP ribosylation activity of CT resides in CTA1. Hence, entry of CTA1 into the cytosol is a crucial step in the intoxication process. This involves the ER-associated degradation pathway, or degradasome, the function of which is to retrieve misfolded proteins from the ER for their degradation in the cytosol. CTA1 escapes degradation in spite of passing through the degradasome, presumably because of its low lysine content, an essential marker for ubiquitination 20 . During transport through the degradasome CTA1 unfolds and refolds, which involves reduction by protein disulphide isomerase and reoxidation by Ero1 21 . CTA1, upon entry into the cytosol, catalyzes the ADP-ribosylation of the trimeric Gsα component of AC ( Fig. 1 ). This leads AC to remain in its GTP-bound state, resulting in enhanced AC activity and increased intracellular cAMP concentrations. High levels of cAMP start a cascade that eventually lead to the severe clinical manifestations of cholera, as has been highlighted above.
The Formation of DNA Methylation Patterns and the Silencing of Genes
1 CIS-ACTING REGULATORY ELEMENTS OF METHYLATION
Most housekeeping genes have CpG islands that are not normally methylated. For example, in the mouse adenine phosphoribosyl transferase ( aprt) gene the CpG islands are totally free of methylation, whereas the flanking regions have methylated CpGs (94) . In a transgenic mouse assay, deletion mutagenesis of the Spl sites flanking the CpG islands of the aprt gene initiated a de novo methylation of the CpG islands. These experiments demonstrated that the peripherally located Spl sites were necessary to keep the aprt CpG islands methylation free (94, 95) . Though certain cis-acting elements can effectively prevent the methylation of DNA, other sequences can enhance DNA methylation. For example, Mummanemi et al. (96) showed conclusively that a cis-acting element located 1.3 kb upstream of the mouse aprt gene acted as a signal for the methylation and epigenetic inactivation of the gene. During X chromosome inactivation, specific sequences in the X inactivation center (XIC) may also play a fundamental role for the spreading of methylation from the XIC in both directions (97) . In the above cases it is clear that cis control elements can prevent or give the signal for de novo methylation. It is, however, not certain by which mechanism they function. Two possibilities, which are not mutually exclusive, should be considered: the structure of the DNA could either enhance or prevent the action of DNA methyltransferase, or there could be an indirect effect mediated by some specific RNA and proteins.
Cells communicate by both inter- and intracellular signaling. Signaling cells secrete ligands that bind to target cells and initiate a chain of events within the target cell. The four categories of signaling in multicellular organisms are paracrine signaling, endocrine signaling, autocrine signaling, and direct signaling across gap junctions. Paracrine signaling takes place over short distances. Endocrine signals are carried long distances through the bloodstream by hormones, and autocrine signals are received by the same cell that sent the signal or other nearby cells of the same kind. Gap junctions allow small molecules, including signaling molecules, to flow between neighboring cells.
Internal receptors are found in the cell cytoplasm. Here, they bind ligand molecules that cross the plasma membrane these receptor-ligand complexes move to the nucleus and interact directly with cellular DNA. Cell-surface receptors transmit a signal from outside the cell to the cytoplasm. Ion channel-linked receptors, when bound to their ligands, form a pore through the plasma membrane through which certain ions can pass. G-protein-linked receptors interact with a G-protein on the cytoplasmic side of the plasma membrane, promoting the exchange of bound GDP for GTP and interacting with other enzymes or ion channels to transmit a signal. Enzyme-linked receptors transmit a signal from outside the cell to an intracellular domain of a membrane-bound enzyme. Ligand binding causes activation of the enzyme. Small hydrophobic ligands (like steroids) are able to penetrate the plasma membrane and bind to internal receptors. Water-soluble hydrophilic ligands are unable to pass through the membrane instead, they bind to cell-surface receptors, which transmit the signal to the inside of the cell.
The primary symptoms of cholera are profuse diarrhea and vomiting of clear fluid.  These symptoms usually start suddenly, half a day to five days after ingestion of the bacteria.  The diarrhea is frequently described as "rice water" in nature and may have a fishy odor.  An untreated person with cholera may produce 10 to 20 litres (3 to 5 US gal) of diarrhea a day.  Severe cholera, without treatment, kills about half of affected individuals.  If the severe diarrhea is not treated, it can result in life-threatening dehydration and electrolyte imbalances.  Estimates of the ratio of asymptomatic to symptomatic infections have ranged from 3 to 100.  Cholera has been nicknamed the "blue death"  because a person's skin may turn bluish-gray from extreme loss of fluids. 
Fever is rare and should raise suspicion for secondary infection. Patients can be lethargic and might have sunken eyes, dry mouth, cold clammy skin, or wrinkled hands and feet. Kussmaul breathing, a deep and labored breathing pattern, can occur because of acidosis from stool bicarbonate losses and lactic acidosis associated with poor perfusion. Blood pressure drops due to dehydration, peripheral pulse is rapid and thready, and urine output decreases with time. Muscle cramping and weakness, altered consciousness, seizures, or even coma due to electrolyte imbalances are common, especially in children. 
Cholera bacteria have been found in shellfish and plankton. 
Transmission is usually through the fecal-oral route of contaminated food or water caused by poor sanitation.  Most cholera cases in developed countries are a result of transmission by food, while in developing countries it is more often water.  Food transmission can occur when people harvest seafood such as oysters in waters infected with sewage, as Vibrio cholerae accumulates in planktonic crustaceans and the oysters eat the zooplankton. 
People infected with cholera often have diarrhea, and disease transmission may occur if this highly liquid stool, colloquially referred to as "rice-water", contaminates water used by others.  A single diarrheal event can cause a one-million fold increase in numbers of V. cholerae in the environment.  The source of the contamination is typically other cholera sufferers when their untreated diarrheal discharge is allowed to get into waterways, groundwater or drinking water supplies. Drinking any contaminated water and eating any foods washed in the water, as well as shellfish living in the affected waterway, can cause a person to contract an infection. Cholera is rarely spread directly from person to person.  [note 1]
V. cholerae also exists outside the human body in natural water sources, either by itself or through interacting with phytoplankton, zooplankton, or biotic and abiotic detritus.  Drinking such water can also result in the disease, even without prior contamination through fecal matter. Selective pressures exist however in the aquatic environment that may reduce the virulence of V. cholerae.  Specifically, animal models indicate that the transcriptional profile of the pathogen changes as it prepares to enter an aquatic environment.  This transcriptional change results in a loss of ability of V. cholerae to be cultured on standard media, a phenotype referred to as 'viable but non-culturable' (VBNC) or more conservatively 'active but non-culturable' (ABNC).  One study indicates that the culturability of V. cholerae drops 90% within 24 hours of entering the water, and furthermore that this loss in culturability is associated with a loss in virulence.  
Both toxic and non-toxic strains exist. Non-toxic strains can acquire toxicity through a temperate bacteriophage. 
About 100 million bacteria must typically be ingested to cause cholera in a normal healthy adult.  This dose, however, is less in those with lowered gastric acidity (for instance those using proton pump inhibitors).  Children are also more susceptible, with two- to four-year-olds having the highest rates of infection.  Individuals' susceptibility to cholera is also affected by their blood type, with those with type O blood being the most susceptible.  Persons with lowered immunity, such as persons with AIDS or malnourished children, are more likely to experience a severe case if they become infected.  Any individual, even a healthy adult in middle age, can experience a severe case, and each person's case should be measured by the loss of fluids, preferably in consultation with a professional health care provider. [ medical citation needed ]
The cystic fibrosis genetic mutation known as delta-F508 in humans has been said to maintain a selective heterozygous advantage: heterozygous carriers of the mutation (who are thus not affected by cystic fibrosis) are more resistant to V. cholerae infections.  In this model, the genetic deficiency in the cystic fibrosis transmembrane conductance regulator channel proteins interferes with bacteria binding to the intestinal epithelium, thus reducing the effects of an infection.
When consumed, most bacteria do not survive the acidic conditions of the human stomach.  The few surviving bacteria conserve their energy and stored nutrients during the passage through the stomach by shutting down protein production. When the surviving bacteria exit the stomach and reach the small intestine, they must propel themselves through the thick mucus that lines the small intestine to reach the intestinal walls where they can attach and thrive. 
Once the cholera bacteria reach the intestinal wall, they no longer need the flagella to move. The bacteria stop producing the protein flagellin to conserve energy and nutrients by changing the mix of proteins that they express in response to the changed chemical surroundings. On reaching the intestinal wall, V. cholerae start producing the toxic proteins that give the infected person a watery diarrhea. This carries the multiplying new generations of V. cholerae bacteria out into the drinking water of the next host if proper sanitation measures are not in place. 
The cholera toxin (CTX or CT) is an oligomeric complex made up of six protein subunits: a single copy of the A subunit (part A), and five copies of the B subunit (part B), connected by a disulfide bond. The five B subunits form a five-membered ring that binds to GM1 gangliosides on the surface of the intestinal epithelium cells. The A1 portion of the A subunit is an enzyme that ADP-ribosylates G proteins, while the A2 chain fits into the central pore of the B subunit ring. Upon binding, the complex is taken into the cell via receptor-mediated endocytosis. Once inside the cell, the disulfide bond is reduced, and the A1 subunit is freed to bind with a human partner protein called ADP-ribosylation factor 6 (Arf6).  Binding exposes its active site, allowing it to permanently ribosylate the Gs alpha subunit of the heterotrimeric G protein. This results in constitutive cAMP production, which in turn leads to the secretion of water, sodium, potassium, and bicarbonate into the lumen of the small intestine and rapid dehydration. The gene encoding the cholera toxin was introduced into V. cholerae by horizontal gene transfer. Virulent strains of V. cholerae carry a variant of a temperate bacteriophage called CTXφ.
Microbiologists have studied the genetic mechanisms by which the V. cholerae bacteria turn off the production of some proteins and turn on the production of other proteins as they respond to the series of chemical environments they encounter, passing through the stomach, through the mucous layer of the small intestine, and on to the intestinal wall.  Of particular interest have been the genetic mechanisms by which cholera bacteria turn on the protein production of the toxins that interact with host cell mechanisms to pump chloride ions into the small intestine, creating an ionic pressure which prevents sodium ions from entering the cell. The chloride and sodium ions create a salt-water environment in the small intestines, which through osmosis can pull up to six liters of water per day through the intestinal cells, creating the massive amounts of diarrhea. The host can become rapidly dehydrated unless treated properly. 
By inserting separate, successive sections of V. cholerae DNA into the DNA of other bacteria, such as E. coli that would not naturally produce the protein toxins, researchers have investigated the mechanisms by which V. cholerae responds to the changing chemical environments of the stomach, mucous layers, and intestinal wall. Researchers have discovered a complex cascade of regulatory proteins controls expression of V. cholerae virulence determinants.  In responding to the chemical environment at the intestinal wall, the V. cholerae bacteria produce the TcpP/TcpH proteins, which, together with the ToxR/ToxS proteins, activate the expression of the ToxT regulatory protein. ToxT then directly activates expression of virulence genes that produce the toxins, causing diarrhea in the infected person and allowing the bacteria to colonize the intestine.  Current [ when? ] research aims at discovering "the signal that makes the cholera bacteria stop swimming and start to colonize (that is, adhere to the cells of) the small intestine." 
Amplified fragment length polymorphism fingerprinting of the pandemic isolates of V. cholerae has revealed variation in the genetic structure. Two clusters have been identified: Cluster I and Cluster II. For the most part, Cluster I consists of strains from the 1960s and 1970s, while Cluster II largely contains strains from the 1980s and 1990s, based on the change in the clone structure. This grouping of strains is best seen in the strains from the African continent. 
In many areas of the world, antibiotic resistance is increasing within cholera bacteria. In Bangladesh, for example, most cases are resistant to tetracycline, trimethoprim-sulfamethoxazole, and erythromycin.  Rapid diagnostic assay methods are available for the identification of multi-drug resistant cases.  New generation antimicrobials have been discovered which are effective against cholera bacteria in in vitro studies. 
A rapid dipstick test is available to determine the presence of V. cholerae.  In those samples that test positive, further testing should be done to determine antibiotic resistance.  In epidemic situations, a clinical diagnosis may be made by taking a patient history and doing a brief examination. Treatment is usually started without or before confirmation by laboratory analysis. [ citation needed ]
Stool and swab samples collected in the acute stage of the disease, before antibiotics have been administered, are the most useful specimens for laboratory diagnosis. If an epidemic of cholera is suspected, the most common causative agent is V. cholerae O1. If V. cholerae serogroup O1 is not isolated, the laboratory should test for V. cholerae O139. However, if neither of these organisms is isolated, it is necessary to send stool specimens to a reference laboratory. [ citation needed ]
Infection with V. cholerae O139 should be reported and handled in the same manner as that caused by V. cholerae O1. The associated diarrheal illness should be referred to as cholera and must be reported in the United States. 
The World Health Organization (WHO) recommends focusing on prevention, preparedness, and response to combat the spread of cholera.  They also stress the importance of an effective surveillance system.  Governments can play a role in all of these areas.
Water, sanitation and hygiene
Although cholera may be life-threatening, prevention of the disease is normally straightforward if proper sanitation practices are followed. In developed countries, due to nearly universal advanced water treatment and sanitation practices present there, cholera is rare. For example, the last major outbreak of cholera in the United States occurred in 1910–1911.   Cholera is mainly a risk in developing countries in those areas where access to WASH (water, sanitation and hygiene) infrastructure is still inadequate.
Effective sanitation practices, if instituted and adhered to in time, are usually sufficient to stop an epidemic. There are several points along the cholera transmission path at which its spread may be halted: 
- Sterilization: Proper disposal and treatment of all materials that may have come into contact with cholera victims' feces (e.g., clothing, bedding, etc.) are essential. These should be sanitized by washing in hot water, using chlorinebleach if possible. Hands that touch cholera patients or their clothing, bedding, etc., should be thoroughly cleaned and disinfected with chlorinated water or other effective antimicrobial agents. and fecal sludge management: In cholera-affected areas, sewage and fecal sludge need to be treated and managed carefully in order to stop the spread of this disease via human excreta. Provision of sanitation and hygiene is an important preventative measure. Open defecation, release of untreated sewage, or dumping of fecal sludge from pit latrines or septic tanks into the environment need to be prevented.  In many cholera affected zones, there is a low degree of sewage treatment.  Therefore, the implementation of dry toilets that do not contribute to water pollution, as they do not flush with water, may be an interesting alternative to flush toilets. 
- Sources: Warnings about possible cholera contamination should be posted around contaminated water sources with directions on how to decontaminate the water (boiling, chlorination etc.) for possible use. : All water used for drinking, washing, or cooking should be sterilized by either boiling, chlorination, ozone water treatment, ultraviolet light sterilization (e.g., by solar water disinfection), or antimicrobial filtration in any area where cholera may be present. Chlorination and boiling are often the least expensive and most effective means of halting transmission. Cloth filters or sari filtration, though very basic, have significantly reduced the occurrence of cholera when used in poor villages in Bangladesh that rely on untreated surface water. Better antimicrobial filters, like those present in advanced individual water treatment hiking kits, are most effective. Public health education and adherence to appropriate sanitation practices are of primary importance to help prevent and control transmission of cholera and other diseases.
Handwashing with soap or ash after using a toilet and before handling food or eating is also recommended for cholera prevention by WHO Africa. 
Dumping of sewage or fecal sludge from a UN camp into a lake in the surroundings of Port-au-Prince is thought to have contributed to the spread of cholera after the Haiti earthquake in 2010, killing thousands.
Example of a urine-diverting dry toilet in a cholera-affected area in Haiti. This type of toilet stops transmission of disease via the fecal-oral route due to water pollution.
Cholera hospital in Dhaka, showing typical "cholera beds".
Surveillance and prompt reporting allow for containing cholera epidemics rapidly. Cholera exists as a seasonal disease in many endemic countries, occurring annually mostly during rainy seasons. Surveillance systems can provide early alerts to outbreaks, therefore leading to coordinated response and assist in preparation of preparedness plans. Efficient surveillance systems can also improve the risk assessment for potential cholera outbreaks. Understanding the seasonality and location of outbreaks provides guidance for improving cholera control activities for the most vulnerable.  For prevention to be effective, it is important that cases be reported to national health authorities. 
Spanish physician Jaume Ferran i Clua developed a cholera inoculation in 1885, the first to immunize humans against a bacterial disease.  However, his vaccine and inoculation was rather controversial and was rejected by his peers and several investigation commissions.    Russian-Jewish bacteriologist Waldemar Haffkine successfully developed the first human cholera vaccine in July 1892.     He conducted a massive inoculation program in British India.  
A number of safe and effective oral vaccines for cholera are available.  The World Health Organization (WHO) has three prequalified oral cholera vaccines (OCVs): Dukoral, Sanchol, and Euvichol. Dukoral, an orally administered, inactivated whole cell vaccine, has an overall efficacy of about 52% during the first year after being given and 62% in the second year, with minimal side effects.  It is available in over 60 countries. However, it is not currently [ when? ] recommended by the Centers for Disease Control and Prevention (CDC) for most people traveling from the United States to endemic countries.  The vaccine that the US Food and Drug Administration (FDA) recommends, Vaxchora, is an oral attenuated live vaccine, that is effective as a single dose. 
One injectable vaccine was found to be effective for two to three years. The protective efficacy was 28% lower in children less than five years old.  However, as of 2010 [update] , it has limited availability.  Work is under way to investigate the role of mass vaccination.  The WHO recommends immunization of high-risk groups, such as children and people with HIV, in countries where this disease is endemic.  If people are immunized broadly, herd immunity results, with a decrease in the amount of contamination in the environment. 
WHO recommends that oral cholera vaccination be considered in areas where the disease is endemic (with seasonal peaks), as part of the response to outbreaks, or in a humanitarian crisis during which the risk of cholera is high.  Oral Cholera Vaccine (OCV) has been recognized as an adjunct tool for prevention and control of cholera. The World Health Organization (WHO) has prequalified three bivalent cholera vaccines—Dukoral (SBL Vaccines), containing a non-toxic B-subunit of cholera toxin and providing protection against V. cholerae O1 and two vaccines developed using the same transfer of technology—ShanChol (Shantha Biotec) and Euvichol (EuBiologics Co.), which have bivalent O1 and O139 oral killed cholera vaccines.  Oral cholera vaccination could be deployed in a diverse range of situations from cholera-endemic areas and locations of humanitarian crises, but no clear consensus exists. 
Developed for use in Bangladesh, the "sari filter" is a simple and cost-effective appropriate technology method for reducing the contamination of drinking water. Used sari cloth is preferable but other types of used cloth can be used with some effect, though the effectiveness will vary significantly. Used cloth is more effective than new cloth, as the repeated washing reduces the space between the fibers. Water collected in this way has a greatly reduced pathogen count—though it will not necessarily be perfectly safe, it is an improvement for poor people with limited options.  In Bangladesh this practice was found to decrease rates of cholera by nearly half.  It involves folding a sari four to eight times.  Between uses the cloth should be rinsed in clean water and dried in the sun to kill any bacteria on it.  A nylon cloth appears to work as well but is not as affordable. 
Continued eating speeds the recovery of normal intestinal function. The WHO recommends this generally for cases of diarrhea no matter what the underlying cause.  A CDC training manual specifically for cholera states: "Continue to breastfeed your baby if the baby has watery diarrhea, even when traveling to get treatment. Adults and older children should continue to eat frequently." 
The most common error in caring for patients with cholera is to underestimate the speed and volume of fluids required.  In most cases, cholera can be successfully treated with oral rehydration therapy (ORT), which is highly effective, safe, and simple to administer.  Rice-based solutions are preferred to glucose-based ones due to greater efficiency.  In severe cases with significant dehydration, intravenous rehydration may be necessary. Ringer's lactate is the preferred solution, often with added potassium.   Large volumes and continued replacement until diarrhea has subsided may be needed.  Ten percent of a person's body weight in fluid may need to be given in the first two to four hours.  This method was first tried on a mass scale during the Bangladesh Liberation War, and was found to have much success.  Despite widespread beliefs, fruit juices and commercial fizzy drinks like cola, are not ideal for rehydration of people with serious infections of the intestines, and their excessive sugar content may even harm water uptake. 
If commercially produced oral rehydration solutions are too expensive or difficult to obtain, solutions can be made. One such recipe calls for 1 liter of boiled water, 1/2 teaspoon of salt, 6 teaspoons of sugar, and added mashed banana for potassium and to improve taste. 
As there frequently is initially acidosis, the potassium level may be normal, even though large losses have occurred.  As the dehydration is corrected, potassium levels may decrease rapidly, and thus need to be replaced.  This may be done by consuming foods high in potassium, like bananas or coconut water. 
Antibiotic treatments for one to three days shorten the course of the disease and reduce the severity of the symptoms.  Use of antibiotics also reduces fluid requirements.  People will recover without them, however, if sufficient hydration is maintained.  The WHO only recommends antibiotics in those with severe dehydration. 
Doxycycline is typically used first line, although some strains of V. cholerae have shown resistance.  Testing for resistance during an outbreak can help determine appropriate future choices.  Other antibiotics proven to be effective include cotrimoxazole, erythromycin, tetracycline, chloramphenicol, and furazolidone.  Fluoroquinolones, such as ciprofloxacin, also may be used, but resistance has been reported. 
Antibiotics improve outcomes in those who are both severely and not severely dehydrated.  Azithromycin and tetracycline may work better than doxycycline or ciprofloxacin. 
In Bangladesh zinc supplementation reduced the duration and severity of diarrhea in children with cholera when given with antibiotics and rehydration therapy as needed. It reduced the length of disease by eight hours and the amount of diarrhea stool by 10%.  Supplementation appears to be also effective in both treating and preventing infectious diarrhea due to other causes among children in the developing world.  
If people with cholera are treated quickly and properly, the mortality rate is less than 1% however, with untreated cholera, the mortality rate rises to 50–60%.  
For certain genetic strains of cholera, such as the one present during the 2010 epidemic in Haiti and the 2004 outbreak in India, death can occur within two hours of becoming ill. 
Cholera affects an estimated 3–5 million people worldwide, and causes 58,000–130,000 deaths a year as of 2010 [update] .   This occurs mainly in the developing world.  In the early 1980s, death rates are believed to have been greater than three million a year.  It is difficult to calculate exact numbers of cases, as many go unreported due to concerns that an outbreak may have a negative impact on the tourism of a country.  Cholera remains [ when? ] both epidemic and endemic in many areas of the world.  In October 2016, an outbreak of cholera began in war-ravaged Yemen.  WHO called it "the worst cholera outbreak in the world". 
Although much is known about the mechanisms behind the spread of cholera, this has not led to a full understanding of what makes cholera outbreaks happen in some places and not others. Lack of treatment of human feces and lack of treatment of drinking water greatly facilitate its spread, but bodies of water can serve as a reservoir, and seafood shipped long distances can spread the disease. Cholera was not known in the Americas for most of the 20th century, but it reappeared towards the end of that century. 
History of outbreaks
The word cholera is from Greek: χολέρα kholera from χολή kholē "bile". Cholera likely has its origins in the Indian subcontinent as evidenced by its prevalence in the region for centuries. 
The disease appears in the European literature as early as 1642, from the Dutch physician Jakob de Bondt's description it in his De Medicina Indorum.  (The "Indorum" of the title refers to the East Indies. He also gave first European descriptions of other diseases.)
Early outbreaks in the Indian subcontinent are believed to have been the result of poor living conditions as well as the presence of pools of still water, both of which provide ideal conditions for cholera to thrive.  The disease first spread by trade routes (land and sea) to Russia in 1817, later to the rest of Europe, and from Europe to North America and the rest of the world,  (hence the name "Asiatic cholera"  ). Seven cholera pandemics have occurred in the past 200 years, with the seventh pandemic originating in Indonesia in 1961. 
The first cholera pandemic occurred in the Bengal region of India, near Calcutta starting in 1817 through 1824. The disease dispersed from India to Southeast Asia, the Middle East, Europe, and Eastern Africa.  The movement of British Army and Navy ships and personnel is believed to have contributed to the range of the pandemic, since the ships carried people with the disease to the shores of the Indian Ocean, from Africa to Indonesia, and north to China and Japan.  The second pandemic lasted from 1826 to 1837 and particularly affected North America and Europe due to the result of advancements in transportation and global trade, and increased human migration, including soldiers.  The third pandemic erupted in 1846, persisted until 1860, extended to North Africa, and reached South America, for the first time specifically affecting Brazil. The fourth pandemic lasted from 1863 to 1875 spread from India to Naples and Spain. The fifth pandemic was from 1881–1896 and started in India and spread to Europe, Asia, and South America. The sixth pandemic started 1899–1923. These epidemics were less fatal due to a greater understanding of the cholera bacteria. Egypt, the Arabian peninsula, Persia, India, and the Philippines were hit hardest during these epidemics, while other areas, like Germany in 1892 (primarily the city of Hamburg where more than 8.600 people died)  and Naples from 1910–1911, also experienced severe outbreaks. The seventh pandemic originated in 1961 in Indonesia and is marked by the emergence of a new strain, nicknamed El Tor, which still persists (as of 2018 [update]  ) in developing countries. 
Cholera became widespread in the 19th century.  Since then it has killed tens of millions of people.  In Russia alone, between 1847 and 1851, more than one million people perished of the disease.  It killed 150,000 Americans during the second pandemic.  Between 1900 and 1920, perhaps eight million people died of cholera in India.  Cholera became the first reportable disease in the United States due to the significant effects it had on health.  John Snow, in England, was the first to identify the importance of contaminated water as its cause in 1854.  Cholera is now no longer considered a pressing health threat in Europe and North America due to filtering and chlorination of water supplies, but still heavily affects populations in developing countries.
In the past, vessels flew a yellow quarantine flag if any crew members or passengers were suffering from cholera. No one aboard a vessel flying a yellow flag would be allowed ashore for an extended period, typically 30 to 40 days. 
Historically many different claimed remedies have existed in folklore. Many of the older remedies were based on the miasma theory. Some believed that abdominal chilling made one more susceptible and flannel and cholera belts were routine in army kits.  In the 1854–1855 outbreak in Naples homeopathic camphor was used according to Hahnemann.  T. J. Ritter's "Mother's Remedies" book lists tomato syrup as a home remedy from northern America. Elecampane was recommended in the United Kingdom according to William Thomas Fernie.  The first effective human vaccine was developed in 1885, and the first effective antibiotic was developed in 1948.
Cholera cases are much less frequent in developed countries where governments have helped to establish water sanitation practices and effective medical treatments.  The United States, for example, used to [ when? ] have a severe cholera problem similar to those in some developing countries. There were three large cholera outbreaks in the 1800s, which can be attributed to Vibrio cholerae's spread through interior waterways like the Erie Canal and routes along the Eastern Seaboard.  The island of Manhattan in New York City touched the Atlantic Ocean, where cholera collected just off the coast. At this time, New York City did not have as effective a sanitation system as it does today, [ when? ] so cholera was able to spread. 
Cholera morbus is a historical term that was used to refer to gastroenteritis rather than specifically cholera. 
Drawing of Death bringing cholera, in Le Petit Journal (1912).
Emperor Pedro II of Brazil visiting people with cholera in 1855.
Hand bill from the New York City Board of Health, 1832—the outdated public health advice demonstrates the lack of understanding of the disease and its actual causative factors.
One of the major contributions to fighting cholera was made by the physician and pioneer medical scientist John Snow (1813–1858), who in 1854 found a link between cholera and contaminated drinking water.  Dr. Snow proposed a microbial origin for epidemic cholera in 1849. In his major "state of the art" review of 1855, he proposed a substantially complete and correct model for the cause of the disease. In two pioneering epidemiological field studies, he was able to demonstrate human sewage contamination was the most probable disease vector in two major epidemics in London in 1854.  His model was not immediately accepted, but it was seen to be the more plausible, as medical microbiology developed over the next 30 years or so. For his work on cholera, John Snow is often regarded as the "Father of Epidemiology".   
The bacterium was isolated in 1854 by Italian anatomist Filippo Pacini,  but its exact nature and his results were not widely known. In the same year, the Catalan Joaquim Balcells i Pascual discovered the bacterium   and in 1856 probably António Augusto da Costa Simões and José Ferreira de Macedo Pinto, two Portuguese men, did the same.  
Cities in developed nations made massive investment in clean water supply and well-separated sewage treatment infrastructures between the mid-1850s and the 1900s. This eliminated the threat of cholera epidemics from the major developed cities in the world. In 1883, Robert Koch identified V. cholerae with a microscope as the bacillus causing the disease. 
Hemendra Nath Chatterjee, a Bengali scientist, who first formulated and demonstrated the effectiveness of oral rehydration salt (ORS) for diarrhea. In his 1953 paper, published in The Lancet, he states that promethazine can stop vomiting during cholera and then oral rehydration is possible. The formulation of the fluid replacement solution was 4 g of sodium chloride, 25 g of glucose and 1000 ml of water.  
Indian medical scientist Sambhu Nath De discovered the cholera toxin, the animal model of cholera, and successfully demonstrate the method of transmission of cholera pathogen Vibrio cholerae. 
Robert Allan Phillips, working at the US Naval Medical Research Unit Two in Southeast Asia, evaluated the pathophysiology of the disease using modern laboratory chemistry techniques and developed a protocol for rehydration. His research led the Lasker Foundation to award him its prize in 1967. 
More recently, in 2002, Alam, et al., studied stool samples from patients at the International Centre for Diarrhoeal Disease in Dhaka, Bangladesh. From the various experiments they conducted, the researchers found a correlation between the passage of V. cholerae through the human digestive system and an increased infectivity state. Furthermore, the researchers found the bacterium creates a hyperinfected state where genes that control biosynthesis of amino acids, iron uptake systems, and formation of periplasmic nitrate reductase complexes were induced just before defecation. These induced characteristics allow the cholera vibrios to survive in the "rice water" stools, an environment of limited oxygen and iron, of patients with a cholera infection. 
In many developing countries, cholera still reaches its victims through contaminated water sources, and countries without proper sanitation techniques have greater incidence of the disease.  Governments can play a role in this. In 2008, for example, the Zimbabwean cholera outbreak was due partly to the government's role, according to a report from the James Baker Institute.  The Haitian government's inability to provide safe drinking water after the 2010 earthquake led to an increase in cholera cases as well. 
Similarly, South Africa's cholera outbreak was exacerbated by the government's policy of privatizing water programs. The wealthy elite of the country were able to afford safe water while others had to use water from cholera-infected rivers. 
According to Rita R. Colwell of the James Baker Institute, if cholera does begin to spread, government preparedness is crucial. A government's ability to contain the disease before it extends to other areas can prevent a high death toll and the development of an epidemic or even pandemic. Effective disease surveillance can ensure that cholera outbreaks are recognized as soon as possible and dealt with appropriately. Oftentimes, this will allow public health programs to determine and control the cause of the cases, whether it is unsanitary water or seafood that have accumulated a lot of Vibrio cholerae specimens.  Having an effective surveillance program contributes to a government's ability to prevent cholera from spreading. In the year 2000 in the state of Kerala in India, the Kottayam district was determined to be "Cholera-affected" this pronouncement led to task forces that concentrated on educating citizens with 13,670 information sessions about human health.  These task forces promoted the boiling of water to obtain safe water, and provided chlorine and oral rehydration salts.  Ultimately, this helped to control the spread of the disease to other areas and minimize deaths. On the other hand, researchers have shown that most of the citizens infected during the 1991 cholera outbreak in Bangladesh lived in rural areas, and were not recognized by the government's surveillance program. This inhibited physicians' abilities to detect cholera cases early. 
According to Colwell, the quality and inclusiveness of a country's health care system affects the control of cholera, as it did in the Zimbabwean cholera outbreak.  While sanitation practices are important, when governments respond quickly and have readily available vaccines, the country will have a lower cholera death toll. Affordability of vaccines can be a problem if the governments do not provide vaccinations, only the wealthy may be able to afford them and there will be a greater toll on the country's poor.   The speed with which government leaders respond to cholera outbreaks is important. 
Besides contributing to an effective or declining public health care system and water sanitation treatments, government can have indirect effects on cholera control and the effectiveness of a response to cholera.  A country's government can impact its ability to prevent disease and control its spread. A speedy government response backed by a fully functioning health care system and financial resources can prevent cholera's spread. This limits cholera's ability to cause death, or at the very least a decline in education, as children are kept out of school to minimize the risk of infection. 
- 's death has traditionally been attributed to cholera, most probably contracted through drinking contaminated water several days earlier.  Tchaikovsky's mother died of cholera,  and his father became sick with cholera at this time but made a full recovery.  Some scholars, however, including English musicologist and Tchaikovsky authority David Brown and biographer Anthony Holden, have theorized that his death was a suicide.  . Ten months after the 2010 earthquake, an outbreak swept over Haiti, traced to a United Nations base of peacekeepers from Nepal.  This marks the worst cholera outbreak in recent history, as well as the best documented cholera outbreak in modern public health. , Polish poet and novelist, is thought to have died of cholera in Istanbul in 1855. , Physicist, a founder of thermodynamics (d. 1832)  , King of France (d. 1836)  , eleventh president of the United States (d. 1849)  , Prussian soldier and German military theorist (d. 1831)  , Chief Justice of the Straits Settlements (1893)  , Serbian-Americaninventor, engineer and futurist known for his contributions to the design of the modern alternating current (AC) electricity supply system, contracted cholera in 1873 at the age of 17. He was bedridden for nine months, and near death multiple times, but survived and fully recovered.
In popular culture
Unlike tuberculosis ("consumption") which in literature and the arts was often romanticized as a disease of denizens of the demimondaine or those with an artistic temperament,  cholera is a disease which almost entirely affects the lower-classes living in filth and poverty. This, and the unpleasant course of the disease – which includes voluminous "rice-water" diarrhea, the hemorrhaging of liquids from the mouth, and violent muscle contractions which continue even after death – has discouraged the disease from being romanticized, or even the actual factual presentation of the disease in popular culture. 
- The 1889 novel Mastro-don Gesualdo by Giovanni Verga presents the course of a cholera epidemic across the island of Sicily, but does not show the suffering of the victims. 
- In Thomas Mann's novellaDeath in Venice, first published in 1912 as Der Tod in Venedig, Mann "presented the disease as emblematic of the final 'bestial degradation' of the sexually transgressive author Gustav von Aschenbach." Contrary to the actual facts of how violently cholera kills, Mann has his protagonist die peacefully on a beach in a deck chair. Luchino Visconti's 1971 film version also hid from the audience the actual course of the disease.  Mann's novella was also made into an opera by Benjamin Britten in 1973, his last one, and into a ballet by John Neumeier for his Hamburg Ballet company, in December 2003.*
- In Gabriel Garcia Márquez's 1985 novel Love in the Time of Cholera, cholera is "a looming background presence rather than a central figure requiring vile description."  The novel was adapted in 2007 for the film of the same name directed by Mike Newell.
In Zambia, widespread cholera outbreaks have occurred since 1977, most commonly in the capital city of Lusaka.  In 2017, an outbreak of cholera was declared in Zambia after laboratory confirmation of Vibrio cholerae O1, biotype El Tor, serotype Ogawa, from stool samples from two patients with acute watery diarrhea. There was a rapid increase in the number of cases from several hundred cases in early December 2017 to approximately 2,000 by early January 2018.  With intensification of the rains, new cases increased on a daily basis reaching a peak on the first week of January 2018 with over 700 cases reported. 
In collaboration with partners, the Zambia Ministry of Health (MoH) launched a multifaceted public health response that included increased chlorination of the Lusaka municipal water supply, provision of emergency water supplies, water quality monitoring and testing, enhanced surveillance, epidemiologic investigations, a cholera vaccination campaign, aggressive case management and health care worker training, and laboratory testing of clinical samples. 
The Zambian Ministry of Health implemented a reactive one-dose Oral Cholera Vaccine (OCV) campaign in April 2016 in three Lusaka compounds, followed by a pre-emptive second-round in December. 
In India, Kolkata city in West Bengal state in the Ganges delta has been described as the "homeland of cholera", with regular outbreaks and pronounced seasonality. In India, where the disease is endemic, cholera outbreaks occur every year between dry seasons (March–April) and rainy seasons (September–October). India is also characterized by high population density, unsafe drinking water, open drains, and poor sanitation which provide an optimal niche for survival, sustenance and transmission of Vibrio cholerae. 
Democratic Republic of Congo
In Goma in the Democratic Republic of Congo, cholera has left an enduring mark on human and medical history. Cholera pandemics in the 19th and 20th centuries led to the growth of epidemiology as a science and in recent years it has continued to press advances in the concepts of disease ecology, basic membrane biology, and transmembrane signaling and in the use of scientific information and treatment design. 
Bacterial pathogens utilize a multitude of methods to invade mammalian hosts, damage tissue sites, and thwart the immune system from responding. One essential component of these strategies for many bacterial pathogens is the secretion of proteins across phospholipid membranes. Secreted proteins can play many roles in promoting bacterial virulence, from enhancing attachment to eukaryotic cells, to scavenging resources in an environmental niche, to directly intoxicating target cells and disrupting their functions. As we discussed in this chapter, these proteins may be transferred out of the bacterial cytoplasm through a variety of mechanisms, usually involving the use of dedicated protein secretion systems. For this reason, the study of protein secretion systems has been an important focus in the field of bacterial pathogenesis. The remaining chapters in this section will offer a more detailed focus on the molecular and functional characteristics of some of these secretion systems.
What Are the Symptoms of Cholera?
Cholera is a disease characterized by severe, watery diarrhea.
Signs and symptoms of cholera include severe, watery diarrhea that comes on rapidly and resembles rice water. The condition can rapidly lead to dehydration and associated symptoms and signs include
- rapid heart rate,
- dry mouth,
- low blood pressure,
- vomiting, and
- wrinkled skin.
The diarrhea is usually painless. Symptoms can vary in severity among affected people. If not treated with fluids and electrolytes, the dehydration that results may be life-threatening.
What is cholera?
Cholera is an acute infectious disease caused by a bacterium, Vibrio cholerae (V. cholerae), which usually results in a painless, watery diarrhea in humans. Some affected individuals have copious amounts of diarrhea and develop dehydration so severe it can lead to death. Most people who get the disease ingest the organisms through food or water sources contaminated with V. cholerae. Although symptoms may be mild, some previously healthy people will develop a copious diarrhea within about one to five days after ingesting the bacteria. Severe disease requires prompt medical care. Hydration (usually by IV with a rehydration solution for the very ill) of the patient, and antibiotics in some individuals, is the key to surviving the severe life-threatening form of the disease. Subtypes of V. cholerae that may cause severe cases include 01 and 0139.
The World Health Organization (WHO) has maps of current and past areas with cholera outbreaks (see WHO reference). It is estimated that about 1.4 million to 4.3 million people are infected worldwide each year, with approximately 28,000-142,000 deaths per year. Only about one in 10 people infected with cholera develop the typical signs and symptoms. Outbreaks of cholera in 2015-2016 include South Sudan, United Republic of Tanzania, and Kenya, with over 216 deaths and most recently, 121 people diagnosed with cholera in Iraq, their first outbreak since 2012 and in Cuba, the first outbreak in over 130 years.
The term cholera has a long history (see history section below) and has been assigned to several other diseases. For example, fowl or chicken cholera is a disease that can rapidly kill chickens and other avian species rapidly with a major symptom of diarrhea. However, the disease-causing agent in fowl is Pasteurella multocida, a gram-negative bacterium. Similarly, pig cholera (also termed hog or swine cholera) can cause rapid death (in about 15 days) in pigs with symptoms of fever, skin lesions, and seizures. This disease is caused by a pestivirus termed CSFV (classical swine fever virus). Neither one of these animal diseases are related to human cholera, but the terminology can be confusing.
What is the history of cholera?
Cholera has likely been affecting humans for many centuries. Reports of cholera-like disease have been found in India as early as 1000 AD. Cholera is a term derived from Greek khole (illness from bile) and later in the 14th century to colere (French) and choler (English). In the 17th century, cholera was a term used to describe a severe gastrointestinal disorder involving diarrhea and vomiting. There were many outbreaks of cholera, and by the 16th century, some were being noted in historical writings. England had several in the 19th century, the most notable being in 1854, when Dr. John Snow did a classic study in London that showed a main source of the disease (resulting in about 500 deaths in 10 days) came from at least one of the major water sources for London residents termed the "Broad Street pump." The pump handle was removed, and the cholera deaths slowed and stopped. The pump is still present as a landmark in London. Although Dr. Snow did not discover the cause of cholera, he did show how the disease could be spread and how to stop a local outbreak. This was the beginning of modern epidemiologic studies. The last reference shows the map Dr. Snow used to identify the pump site.
V. cholerae was first isolated as the cause of cholera by Filippo Pacini in 1854, but his discovery was not widely known until Robert Koch (who also discovered the cause of tuberculosis), working independently 30 years later, publicized the knowledge and the means of fighting the disease. The history of cholera repeats itself. The U.S. National Library of Medicine houses original documents about multiple cholera outbreaks in the U.S. from the 1820s to the 1900s, with the last large outbreak in 1910-1911. Since the 1800s, there have been seven cholera pandemics (worldwide outbreaks). The seventh pandemic of cholera started in 1961 and lasted until 1975 some researchers think the occasional outbreaks (even up to the present time) represent remnants of the seventh pandemic.
Cholera riots occurred in Russia and England (1831) and in Germany (1893) when the people rebelled against strict government isolation (quarantines) and burial rules. In 2008, cholera riots broke out in Zimbabwe as police tried to disperse people who tried to withdraw funds from banks and were protesting because of the collapse of the health system that began with a cholera outbreak. Similar but less violent public protests have occurred when yellow fever, typhoid fever, and tuberculosis quarantines have been enforced by health authorities.
Multiple outbreaks continue into the 21st century, with outbreaks in India, Iran, Vietnam, and several African countries over the last 10 years. Some recent outbreaks occurred in Haiti and Nigeria in 2010-2011, and South Sudan, Tanzania, Iraq, Kenya, and Cuba in 2015-2016, and Yemen in 2017-18. Since 2017-2018, the WHO has listed 1,084,191 suspected cases of cholera with 2,267 associated deaths in war-torn Yemen.
Why is cholera history repeating itself? The answer can be traced back to Dr. Snow's studies that show a source (water-borne or occasionally food) contaminated with V. cholerae can easily and rapidly transmit the cholera-causing bacteria to many people. Until safe, clean water and food is available to all humans, it is likely that cholera outbreaks will continue to happen.
Symptoms and treatment
Cholera is marked by the sudden onset of profuse, watery diarrhea, typically after an incubation period of 12 to 28 hours. The fluid stools, commonly referred to as “rice water” stools, often contain flecks of mucus. The diarrhea is frequently accompanied by vomiting, and the patient rapidly becomes dehydrated. The patient is very thirsty and has a dry tongue. The blood pressure falls, the pulse becomes faint, and muscular cramps may become severe. The patient’s eyes become hollow and sunken, and the skin becomes wrinkled, giving the hands the appearance of “washerwoman’s hands.” Children may also experience fever, lethargy, and seizures as a result of the extreme dehydration. The disease ordinarily runs its course in two to seven days.
The rapid loss of fluid from the bowel can, if untreated, lead to death—sometimes within hours—in more than 50 percent of those stricken. However, with proper modern treatment, mortality can essentially be prevented, with rates kept to less than 1 percent of those requiring therapy. This treatment consists largely of replacing lost fluid and salts with the oral or intravenous administration of an alkaline solution of sodium chloride. For oral rehydration the solution is made by using oral rehydration salts (ORS)—a measured mixture of glucose, sodium chloride, potassium chloride, and trisodium citrate. The mixture can be prepackaged and administered by nonmedical personnel, allowing cholera to be treated even under the most adverse conditions. ORS can generally be used to treat all but the most severely dehydrated patients, who require intravenous rehydration.
The administration of antibiotics such as tetracycline during the first day of treatment usually shortens the period of diarrhea and decreases the amount of fluid replacement required. It is also important for patients to resume eating as soon as they are able in order to avoid malnutrition or to prevent existing malnutrition from becoming worse.
In order for researchers to understand how Vibrio fischeri and its host, Euprymna scolopes, communicate, they began to look for bacterial genes that were involved in the colonization of the symbiotic light organ. They expected that Vibrio fischeri mutants that were unable to reach high cell densities in the light organs would also reveal deficiencies in their symbiotic luminescence levels. They were indeed correct. They identified two mutants, KV712 and KV733, that had significant colonization defects by screening a library of mutant Vibrio fischeri cells (Miyamoto, M.C., Lin,H.Y., Meighen,A.E.). The similarity of the sequences between the gene defective in KV712, also known as RscS (regulator of symbiotic colonization), and sensory kinases allowed them to predict the role of RscS in the symbiosis. Researchers believed that the periplasmic loop of RscS recognized the signal sent by the squid. The signal was then transmitted to a response regulator protein(RscR), which in turn functioned to increase the transcription of genes required for the symbiotic phase of the Vibrio fischeri life cycle (Yip, E.S., et al.).
Currently, researchers are trying to find the critical time points during which bacterial signaling occurs. In order to facilitate the process, they have constructed cDNA libraries at these time points of both aposymbiotic and symbiont juveniles (Visick, KL and MJ McFall-Ngai). They are now subtracting these libraries to determine the gene expression brought about by interaction with Vibrio fischeri. Once potential genes have been identified, they will then conduct further research concerning the timing and location of gene expression in colonized host tissues.
Discoveries have been made that Vibrio fischeri de-regulates the expression of the peroxidase gene in tissues where it acts as a beneficial symbiont and conversely up-regulates the expression of the peroxidase gene in tissues where it is viewed as a pathogen (Small, AL and MJ McFall-Ngai). This illustrates the fact that some of the same genes are involved in the control of beneficial and pathogenic associations. Therefore, it is the modulation of the genes that describes the outcome of the relationship.